MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
299.11%
Quick Ratio
238.40%
Cash Ratio
167.00%
Debt to Asset Ratio
126.56%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Inventory
    • Accounts receivable, net of allo...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
30,424
39,541
50,845
29,713
Accounts receivable, net of allowances of 522 and 287
9,637
9,715
10,347
11,274
Inventory
11,059
12,213
11,016
11,558
Prepaid expenses and other current assets
3,371
2,833
3,373
3,503
Total current assets
54,491
64,302
75,581
56,048
Property and equipment, net
2,048
2,157
2,226
2,213
Intangible assets, net
1,169
1,264
1,359
1,454
Right-of-use assets
1,379
1,442
1,502
1,560
Deferred tax asset, net
-
-
-
62
Other long-term assets
451
476
500
-
Restricted cash
200
250
250
250
Total assets
59,738
69,891
81,418
61,587
Accounts payable
2,883
3,894
2,309
2,373
Accrued expenses and other current liabilities
15,335
13,939
15,666
14,604
Total current liabilities
18,218
17,833
17,975
16,977
Long-term debt
56,081
55,866
55,653
41,494
Other long-term liabilities
1,305
1,393
1,477
1,559
Total liabilities
75,604
75,092
75,105
60,030
Common stock 0.001 par value 200,000,000 shares authorized 44,833,942 and 44,538,264 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
45
45
44
40
Additional paid-in capital
405,101
404,503
403,739
389,946
Accumulated other comprehensive income
84
85
91
91
Accumulated deficit
-421,096
-409,834
-397,561
-388,520
Total stockholders' (deficit) equity
-15,866
-5,201
6,313
1,557
Total liabilities and stockholders' (deficit) equity
59,738
69,891
81,418
61,587
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$30,424K (-13.02%↓ Y/Y)Inventory$11,059K (-2.74%↓ Y/Y)Accounts receivable, netof allowances of...$9,637K (-14.23%↓ Y/Y)Prepaid expenses andother current assets$3,371K (6.64%↑ Y/Y)Total current assets$54,491K (-10.30%↓ Y/Y)Property and equipment,net$2,048K (-5.49%↓ Y/Y)Right-of-use assets$1,379K (-14.67%↓ Y/Y)Intangible assets, net$1,169K (-24.53%↓ Y/Y)Other long-termassets$451K (-60.12%↓ Y/Y)Restricted cash$200K (-24.53%↓ Y/Y)Total assets$59,738K (-11.55%↓ Y/Y)Accumulated deficit-$421,096K (-10.84%↓ Y/Y)Total liabilities andstockholders' (deficit)...$59,738K (-11.55%↓ Y/Y)Total stockholders'(deficit) equity-$15,866K (-272.76%↓ Y/Y)Additional paid-in capital$405,101K (4.15%↑ Y/Y)Accumulated othercomprehensive income$84K (-9.68%↓ Y/Y)Common stock 0.001 parvalue 200,000,000...$45K (12.50%↑ Y/Y)Total liabilities$75,604K (29.56%↑ Y/Y)Long-term debt$56,081K (47.38%↑ Y/Y)Total currentliabilities$18,218K (-4.42%↓ Y/Y)Other long-termliabilities$1,305K (5.16%↑ Y/Y)Accrued expenses andother current...$15,335K (9.64%↑ Y/Y)Accounts payable$2,883K (65.59%↑ Y/Y)

TELA Bio, Inc. (TELA)

TELA Bio, Inc. (TELA)